Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.34 |
| ▸ | FDPS | P14324 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8397532 | 0.83 | ALOX15 (0.67) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL8059226 | 0.83 | ALOX15 (0.67) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL4448966 | 0.82 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL27200268 | 0.82 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL14581768 | 0.82 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL17955374 | 0.82 | ALOX15 (0.65) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL1292971 | 0.81 | ALOX15 (0.59) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL4406232 | 0.81 | ALOX15 (0.59) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL13802845 | 0.80 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 | |
| SCHEMBL17955363 | 0.80 | ALOX15 (0.62) | ALOX15ALDH1A1NFE2L2USP2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572938-B2 | Precursors for ketones and aldehydes | GIVAUDAN SA (CH) | 2009-08-11 | — | — | US | claimed |
| US-20040171516-A1 | Precursors for ketones and aldehydes | GIVAUDAN SA (CH) | 2004-09-02 | — | — | US | claimed |
| EP-1390337-A1 | PRECURSORS FOR KETONES AND ALDEHYDES | Givaudan SA (CH) | 2004-02-25 | — | — | EP | claimed |
| WO-2002096850-A1 | PRECURSORS FOR KETONES AND ALDEHYDES | GIVAUDAN SA (CH) | 2002-12-05 | — | — | WO | claimed |
| EP-1262473-A1 | Precursors for fragrant ketones and fragrant aldehydes | Givaudan SA (CH) | 2002-12-04 | — | — | EP | claimed |
| US-7572938-B2 | Precursors for ketones and aldehydes | GIVAUDAN SA (CH) | 2009-08-11 | — | — | US | disclosed |
| US-20040171516-A1 | Precursors for ketones and aldehydes | GIVAUDAN SA (CH) | 2004-09-02 | — | — | US | disclosed |
| EP-1262473-A1 | Precursors for fragrant ketones and fragrant aldehydes | Givaudan SA (CH) | 2002-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171516-A1 | Precursors for ketones and aldehydes | PDK3, PDK4, AKR1C4 | ALOX15 513/4885ALDH1A1 13/4885NFE2L2 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.